南北水 | 南水逆勢加倉藥明康德4.13億元,北水大幅拋售汽車股、港股ETF
8月9日,北上資金今日淨賣出A股13.32億元,為連續第三日淨賣出。其中滬股通淨賣出14.12億元,深股通淨買入8016.56萬元。
招商銀行、貴州茅台、比亞迪分別遭淨賣出3.84億元、2.89億元、2.34億元。藥明康德淨買入額居首,金額為4.13億元。

南下資金今日淨賣出港股68.81億港元。其中港股通(滬)淨賣出16.11億港元,港股通(深)淨賣出52.70億港元。
盈富基金、恒生中國企業、南方恒生科技分別遭淨賣出35.5億港元、22.34億港元、7.12億港元;中國海洋石油逆勢獲淨買入2.21億港元。

南水關注個股
醫藥板塊回暖,藥明康德獲淨買入4.13億,邁瑞醫療獲淨買入2.59億。德邦證券指出,醫療反腐或為醫藥板塊最後一次調整:1)人民對健康的需求不會因反腐而降低,醫藥的消費屬性仍在,醫保的支出仍持續增長,23年1-6月醫保支出增長達18.2%;2)估值明確底部,目前TTM估值約26倍,考慮到COVID-19影響,距離22年9月底的估值大底向下空間有限;3)配置低配:根據Q2基金持倉分析,全基持倉7%左右,經過一週的情緒宣泄,判斷全基醫藥持倉或在5%以內,嚴重低配;整體上醫藥短期迴避政策影響,中長期看好創新發展,當前醫藥賠率和勝率較高,值得重點配置。
招商銀行遭淨賣出3.84億元。根據香港聯交所8月8日披露的文件,摩根大通於8月2日以場內每股均價36.8924港元,場外每股均價36.7105港元合計售出招商銀行648.77萬股H股股份,價值約2.39億港元。售出後,摩根大通最新持股數目為2.75億股股份,好倉比例由6.12%降至5.98%。
北水關注個股
汽車板塊遭拋售,理想汽車遭淨賣出3.95億港元,小鵬汽車遭淨賣出2.78億港元。據乘聯會數據顯示,2023年7月乘用車市場零售達到177.5萬輛,同比下降2.3%,環比下降6.3%。7月新能源乘用車批發銷量達到73.7萬輛,同比增長30.7%,環比下降3.1%。隨着車市進入傳統淡季,對於渠道、廠商的銷售壓力也開始回升。進入8月後已有多家車企開啟“降價模式”,車市價格戰似有重燃態勢。東莞證券指出,汽車銷量不及預期、市場競爭加劇的風險仍然存在。
中國海洋石油逆勢獲淨買入2.21億港元,南下資金已連續3日淨買入中海油,累計約9.496億港元。瑞銀表示未來油價保持樂觀的態度,預計到2023年底布倫特原油價格將達到90美元/桶。在8月份,受中國、印度、巴西和中東推動,石油需求有望首次達到1.03億桶/日。鑑於沙特阿拉伯和俄羅斯主導的減產和出口延長,預計未來幾周石油供應將繼續緊張,7月和8月市場供應短缺約200萬桶/日。
康希諾生物獲淨買入1.19億港元。公司與阿斯利康簽署了《產品供應合作框架協議》,公司將向阿斯利康提供合同開發和生產服務以支持其mRNA疫苗項目,生產和供應特定產品,並提供相關特定服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.